Michael Schlichting

Michael Schlichting2021-06-11T08:57:30+01:00

Michael Schlichting is Director Biostatistics at Merck KGaA. Global. Michael co-leads Work Package 2.

He is biostatistical lead for several oncology compounds since 1995, a PRO subject matter expert, and lead HTA biostatistician.

The SISAQOL-IMI Project has received funding from the Innovative Health Initiative 2 joint undertaking under grant agreement No 945052. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.